Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity. (Q53271841)

12 May 2018

title

Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity. (English)

1 reference

12 May 2018

0 references

1

1 reference

12 May 2018

Bernd C Kieseier

11

object named as

Bernd C Kieseier

1 reference

12 May 2018

12

Michael Weller

1 reference

12 May 2018

3

Michel Mittelbronn

1 reference

12 May 2018

9

Richard Meyermann

1 reference

12 May 2018

10

Amit Bar-Or

1 reference

12 May 2018

author name string

Ute Feger

2

1 reference

12 May 2018

Carolyn Jack

4

1 reference

12 May 2018

Bettina Schreiner

5

1 reference

12 May 2018

Christine Stadelmann

6

1 reference

12 May 2018

Jack Antel

7

1 reference

12 May 2018

Wolfgang Brueck

8

1 reference

12 May 2018

language of work or name

English

0 references

publication date

25 August 2005

1 reference

12 May 2018

published in

Brain

1 reference

12 May 2018

volume

128

1 reference

12 May 2018

issue

Pt 11

1 reference

12 May 2018

page(s)

2689-2704

1 reference

12 May 2018

HLA-G and NK receptor are expressed in psoriatic skin: a possible pathway for regulating infiltrating T cells?

cites work

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH609

HLA-G suppresses proliferation of CD4(+) T-lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH609

Monocyte/macrophage differentiation in early multiple sclerosis lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH609

HLA-G: a shield against inflammatory aggression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH609

HLA-G molecules: from maternal-fetal tolerance to tissue acceptance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH609

Patterns of cerebrospinal fluid pathology correlate with disease progression in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH609

Identification of a thymic epithelial cell subset sharing expression of the class Ib HLA-G molecule with fetal trophoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH609

Nervous tissue as an immune compartment: the dialect of the immune response in the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH609

Presence of detectable levels of soluble HLA-G molecules in CSF of relapsing-remitting multiple sclerosis: relationship with CSF soluble HLA-I and IL-10 concentrations and MRI findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH609

Beneficial effect of interferon-beta 1b treatment in patients with relapsing-remitting multiple sclerosis is associated with an increase in serum levels of soluble HLA-I molecules during the first 3 months of therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH609

Blood monocytes consist of two principal subsets with distinct migratory properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH609

New concepts in the immunopathogenesis of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH609

Basic principles of immunological surveillance of the normal central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH609

Expression of major histocompatibility complex class I molecules on the different cell types in multiple sclerosis lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH609

Biotechnological agents for the immunotherapy of multiple sclerosis. Principles, problems and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH609

Type 2 monocyte and microglia differentiation mediated by glatiramer acetate therapy in patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH609

Expression of CCR7 in multiple sclerosis: implications for CNS immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH609

A class I antigen, HLA-G, expressed in human trophoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH609

Microglia: a sensor for pathological events in the CNS

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH609

Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH609

HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH609

A Specific Interferon (IFN)-stimulated Response Element of the Distal HLA-G Promoter Binds IFN-regulatory Factor 1 and Mediates Enhancement of This Nonclassical Class I Gene by IFN-β

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH609

HLA-G1-expressing antigen-presenting cells induce immunosuppressive CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH609

Implication of HLA-G molecule in heart-graft acceptance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH609

Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: a CD4+ T cell regulatory mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH609

Human leukocyte antigen-G expression after heart transplantation is associated with a reduced incidence of rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH609

Monocytes and T lymphocytes in HIV-1-positive patients express HLA-G molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH609

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH609

Recombinant HLA-G5 and -G6 drive U937 myelomonocytic cell production of TGF-beta1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH609

Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH609

Glucocorticoid hormones upregulate levels of HLA-G transcripts in trophoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH609

The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH609

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH609

HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH609

A revised view of the central nervous system microenvironment and major histocompatibility complex class II antigen presentation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH609

A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH609

Three or more routes for leukocyte migration into the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH609

HLA-G1 co-expression boosts the HLA class I-mediated NK lysis inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH609

Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH609

HLA-G in transplantation: a relevant molecule for inhibition of graft rejection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH609

Multiple sclerosis: brain-infiltrating CD8+ T cells persist as clonal expansions in the cerebrospinal fluid and blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH609

A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH609

The non-classical MHC molecule HLA-G protects human muscle cells from immune-mediated lysis: implications for myoblast transplantation and gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH609

Muscle fibres and cultured muscle cells express the B7.1/2-related inducible co-stimulatory molecule, ICOSL: implications for the pathogenesis of inflammatory myopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH609

Express and protect yourself: the potential role of HLA-G on muscle cells and in inflammatory myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH609

Differential proliferative response of human and mouse astrocytes to gamma-interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH609

Constitutive expression of a costimulatory ligand on antigen-presenting cells in the nervous system drives demyelinating disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH609

HLA-G Expression in Atopic Dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH609

21 January 2018

Identifiers

DOI

10.1093/BRAIN/AWH609

1 reference

12 May 2018

PubMed ID

16123145

1 reference

12 May 2018